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Human red cells of various Rh phenotypes were surface-labelled with 125I and the Rh-specific labelled poly- 
peptides were isolated by preparative SDS-PAGE. The polypeptides were subjected to limited proteolysis 
and the resulting fragments were analysed by SDS-PAGE and autoradiography. Chymotryptic peptide 
maps of proteins obtained from Rh(D)-positive and -negative types appeared completely identical, whereas 
tryptic peptide maps revealed a difference: a fragment of M, 17500 was associated with the Rh(D) antigen, 
and one of M, 19000 with the Rh(C/c,E/e) antigens. Treatment of Rh polypeptides with carboxypeptidase 
Y prior to tryptic digestion resulted in a shift of nearly all tryptic fragments, including a fragment of M, 
8000, indicating that the surface label was incorporated into the C-terminal part of the molecule. 
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1. INTRODUCTION 
The blood group Rhesus (Rh) antigens of human 
red cells [ 1,2] have recently been characterized as 
integral membrane proteins of apparent M, 
-30000 [3-81. The Rh(D) polypeptide was found 
to be very hydrophobic and seemed to lack car- 
bohydrate residues [5]. Moreover, the Rh(D) pro- 
tein was shown to be linked to the red cell 
membrane skeleton [9-l 11. Using special elec- 
trophoretic conditions the Rh(D) polypeptide was 
found to be distinct from Rh(c,E) polypeptide(s) 
[7], thereby supporting the two-locus theory for 
the genetic control of Rh antigen expression [ 121. 
We present evidence from proteolysis studies that 
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the Rh(D) and Rh(C/c,E/e) polypeptides are 
distinct, but highly homologous proteins. 
2. MATERIALS AND METHODS 
2.1. Materials 
Rh-typed human red cells were kindly provided 
by the Institut fur Blutgruppenserologie, Universi- 
ty of Vienna. Red cell samples of rare Rh 
phenotypes were gifts from Drs C.C. Entwistle 
(Oxford), R.Y. Harding (Toronto), P.D. Issitt 
(Miami), 0. Jensson (Reykjavik), and S. Muller 
(Dudingen). Antisera were from Behringwerke and 
Ortho, “‘1 from Amersham, a-chymotrypsin and 
TPCK-trypsin from Serva, and carboxypeptidase 
Y from Sigma. Analytical grade reagents were 
from Serva and Merck. 
2.2. Labelling of red ceils and identification of 
Rh-specific polypeptides 
Rh-typed human erythrocytes were ‘251-labelled 
(1 mCi10.2 ml packed cells) by the Iodo-Gen 
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method [ 131. The membranes were isolated and 
immunoprecipitation of Rh antigens carried out as 
in [3,5]. 
2.3. Purification of Rh-specific polypeptides 
Rh proteins were purified from 1251-labelled red 
cell membranes (equivalent to 1 ml packed red 
cells) by preparative SDS-PAGE [14] (10% 
acrylamide). The gels were exposed to Kodak XAR 
film and the Rh-specific bands excised according 
to the autoradiogram. Electrophoretically eluted 
[ 151 Rh proteins were further purified by a second 
step of SDS-PAGE (17% acrylamide), elec- 
trophoretic elution and dialysis. The Rh proteins 
were then adsorbed to phenyl-Sepharose CL4B (2 
x 1 cm, equilibrated with 10 mM Tris-Cl, pH 7.5). 
After washing with 20 ml equilibrating buffer the 
column was eluted with 20 ml of 0.5% SDS in 
equilibrating buffer. The fractions containing 
MrxlO-3 a b c d 8 f g 
97- I)’ 
radioactivity were pooled, dialysed against 1 mM 
EDTA and 0.05% NaN3 and lyophilised. 
2.4. Limited proteolysis of Rh-specific 
polypeptides 
Lyophilised Rh proteins (-10000 cpm) were 
dissolved in 40 ,~l of 20 mM Tris-Cl, pH 7.5, and 
10~1 protease solution (containing 1-lO,~g pro- 
tease) were added. The mixture was incubated for 
2-5 h at 37°C and the reaction terminated by addi- 
tion of 15 ~1 of 5-fold sample buffer [14] and 
heating for 3 min at 100°C. The peptides were 
separated by SDS-PAGE (17% acrylamide); the 
gels were dried and exposed to Kodak XAR film. 
2.5. Carboxypeptidase Y digestion of Rh-specific 
polypeptides 
Lyophilised Rh proteins (-10000 cpm) were 
dissolved in 40~1 of 20 mM N-ethylmorpholine 
acetate buffer, pH 7.0, and 10 ~1 carboxypeptidase 
Y solution (0.1 mg/ml) were added. The mixture 
was incubated for 12 h at 37°C the reaction being 
terminated by heating for 3 min at 100°C followed 
by lyophilisation. 
x w3 
29- ( 
Fig.1. SDS-PAGE patterns of ‘251-labelled red cell 
membranes and of purified Rh-specific polypeptides. (a) 
Super-D (-D-/-D-) membranes, (b) cDE/cDE 
membranes, (c) cDe/cde membranes, (d) cde/cde 
membranes, (e) Rh,,rr (---I---) membranes, (f) 
immunoprecipitated Rh(D) protein, obtained from 
Super-D membranes with anti-Rh(D) antiserum, (g) 
purified Rh polypeptide(s) from cde/cde membranes. 
The arrow indicates the position of Rh-specific proteins. 
Acrylamide concentration, 12%. 
18- 
Fig.2. Peptide maps obtained from chymotryptic digests 
of purified Rh proteins from the phenotypes (a) -D-/-D-, 
(b) CDe/CDe, (c) cDE/cDE, (d) cDe/cde, (e) cde/cde. 
Acrylamide concentration, 17%. 
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3. RESULTS AND DISCUSSION 
3.1. Purification of Rh-specific polypeptides 
The Rh-specific proteins of A4, -30000 were 
easily recognized when ‘251-labelled red cell mem- 
branes of different Rh phenotypes were analysed 
by SDS-PAGE, as described by others [3-61 
(fig. 1). Rh(D)-positive membranes showed a 
strongly labelled band of M, -30000, whereas this 
band was visible only after prolonged exposure 
when Rh(D)-negative (cde/cde) membranes were 
analysed. Rh,,u membranes lacked the band of M, 
- 30000. 
We purified the Rh-specific proteins via two 
steps of preparative SDS-PAGE. 10% acrylamide 
gels gave optimal separation of Rh proteins from 
the glycophorins, 17% acrylamide gels being used 
for further purification from minor contaminants. 
Phenyl-Sepharose columns were used for the 
separation of Rh proteins from electrophoresis 
chemicals. The isolated Rh proteins showed the 
M,x10-3 
66- 
45- 
29- 
18- 
characteristic properties, as described [5], and co- 
migrated with immunoprecipitated .Rh protein 
(fig. 1). 
3.2. Peptide mapping of Rh-specific polypeptides 
Rh-specific proteins were digested with 
chymotrypsin or trypsin under conditions of 
limited proteolysis and were analysed by SDS- 
PAGE. The chymotryptic peptide maps of Rh pro- 
teins from Rh(D)-positive and -negative types ap- 
peared to be completely identical, indicating a high 
degree of structural homology between these pro- 
teins (fig.2). 
In contrast, the tryptic peptide maps revealed a 
characteristic difference: a fragment of M, 17500 
was associated with the Rh(D) antigen and one of 
M, 19000 with the Rh(C/c,E/e) antigens (fig.3). 
This result supports other evidence that the Rh(D) 
Mrx low3 a b c d 
45- 
29- 
a I 
18- 
14- 
c 
Fig.3. Peptide maps obtained from tryptic digests of 
purified Rh proteins from the phenotypes (a) -D-/-D-, 
(b) CDe/CDe, (c) cDE/cDE, (d) cDe/cde, (e) cde/cde. 
Arrows indicate the positions of the two characteristic 
fragments described in the text. Acrylamide 
concentration, 17%. 
Fig.4. Peptide maps obtained from tryptic digests of 
purified cDe/cde protein(s), with or without prior 
treatment with carboxypeptidase Y. (a) Purified 
protein(s), (b) carboxypeptidase Y-digested protein(s), 
(c) tryptic peptide map of purified protein(s), (d) tryptic 
peptide map of carboxypeptidase Y-digested protein(s). 
Acrylamide concentration, 17%. 
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protein is not identical with the Rh(C/c,E/e) pro- 
tein(s) [3,7,12]. Chemical modification studies in- 
volving arginine or lysine residues [16,17] in 
combination with tryptic peptide mapping showed 
that the Rh(D)-specific fragment is generated by 
cleavage at an arginine residue, whereas the frag- 
ment of M, 19000 is generated by cleavage at a 
lysine residue (not shown). 
3.3. Peptide mapping of carboxypeptidase 
Y-digested R&specific polypeptides 
Incubation of Rh proteins with carboxypep- 
tidase Y resulted in degradation of the polypeptide 
chains showing a decrease in M, value of 1500 
(fig.4). The tryptic peptide maps of untreated and 
carboxypeptidase Y-treated Rh proteins also ex- 
hibited a decrease in M, value of 1500 for nearly all 
fragments, including one of M, 8000. This result 
indicates that the surface label was incorporated 
into the C-terminal part of the molecules, sug- 
gesting further that the exposed Rh-specific 
epitopes are located in this region. However, we 
cannot exclude the possibility that other 
characteristic portions of the Rh proteins are also 
exposed at the cell surface, but are not ‘*‘I- 
labelled. Alternative labelling methods should help 
to clarify this problem. 
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